Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Bronchial artery infusion uses a catheter to deliver antitumor substances directly
to the lungs. Drugs used in chemotherapy, such as gemcitabine, work in different ways to stop
tumor cells from dividing so they stop growing or die. Giving gemcitabine in different ways
may kill more tumor cells.
PURPOSE: This phase I trial is studying the side effects and best dose of gemcitabine given
by bronchial artery infusion and to see how well it works in treating patients with recurrent
or progressive non-small cell lung cancer.